Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial

Weishaupt, Carsten; Stroelin, Anke; Kahle, Birgit; Kreuter, Alexander; Schneider, Stefan W.; Gerss, Joachim; Eveslage, Maria; Drabik, Attyla; Goerge, Tobias

dc.contributor.author	Strölin, Anke
dc.date.accessioned	2017-03-15T14:57:05Z
dc.date.available	2017-03-15T14:57:05Z
dc.date.issued	2016
dc.identifier.issn	2352-3026
dc.identifier.uri	http://hdl.handle.net/10900/75081
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/S2352-3026(15)00251-3	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160915142648_01848
utue.publikation.seiten	E72-E79	de_DE
utue.personen.roh	Weishaupt, Carsten
utue.personen.roh	Stroelin, Anke
utue.personen.roh	Kahle, Birgit
utue.personen.roh	Kreuter, Alexander
utue.personen.roh	Schneider, Stefan W.
utue.personen.roh	Gerss, Joachim
utue.personen.roh	Eveslage, Maria
utue.personen.roh	Drabik, Attyla
utue.personen.roh	Goerge, Tobias
dcterms.isPartOf.ZSTitelID	Lancet Haematology	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	3	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE